Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.

Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Tonix Pharmaceuticals and Makana Therapeutics will collaborate on preclinical xenotransplantation research and development.
The FDA has granted Priority Review to pegcetacoplan to treat C3 glomerulopathy and primary IC-MPGN.
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit.
At the NephCure Patient Summit, Montrez Lucas presented a session on how people with kidney disease can navigate insurance.
Dr. Purva Sharma educated patients with kidney disease about clinical trials in a NephCure 2025 Patient Summit session.
Social worker Janay Thompson shared mental health tips for patients with kidney disease at the NephCure 2025 Patient Summit.
Dr. Thomas Pham spoke to us about kidney donation during National Donate Life Month.
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Expert Interviews
Conferences
Podcasts
Listen to the discussion of Chapter 18 of Dr. Burton Rose's book, focused on metabolic alkalosis.
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Listen to the discussion of Chapter 17 of Dr. Burton Rose's book, focused on simple and mixed acid-base disorders.
Expert Columns
Ajay Singh discusses the state of rare kidney disease research.
Sarah Tolson highlights the concerns and challenges dialysis programs face under the 2025 ESRD PPS requirements.
Dr. Ajay Singh and others pay tribute to Dr. Barry Brenner, a leading nephrologist who passed away in August 2024.
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.